Magen OrthoMed

Adhesion Barriers for Scar Prevention

Health Tech & Life Sciences
Non Active, Jan 2014
Seed Ashkelon Founded 2011
Total raised
$500K
Last: Seed
Stage
Seed
Founded
2011
Headcount
6
HQ
Ashkelon
Sector
Health Tech & Life Sciences

About

Magen OrthoMed is developing adhesion barriers by implanting a temporary synthetic barrier that physically prevents scar tissue from proliferating and adhering to anatomic structures such as spinal dura, nerves, tendons, or ligaments. Magen's adhesion barriers can reduce the extent of scar tissue adhesion to the structureand provide a clear surgical plane between the naturally forming scar tissue and the structure, to enable easier and safer dissection in re-operations performed at the same surgical site. Magen's adhesion barriers are implanted at the end of the surgical procedure and are removed in an out-patient follow-up physician visit, after about 30 days. Magen's SpineShield is a barrier thatprotects the spinal canal from penetrating scar tissue. It is removed from the body after healing has taken place, leaving a separation between the spinal canal and surrounding scar tissue. The SpineShield is a protective synthetic membrane thatis placed over the gap from which the lamina was removed. It protects the spinal canal as the lamina would, so that no scar tissue connects to the spinal cord ornerves.

Funding history · 1 round · $500K total

Date unknown
Seed $500K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcareProviders
Business model
B2B

Tags

orthopedicspreventionpatent-pendingmedical-technologiestissue-regenerationneurologysurgerymedical-devices